Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richmond Hill Investment Co. is a New York-based investment advisory firm that specializes in opportunistic investments across the life sciences, biotechnology, and healthcare sectors. Established in 2008, the firm manages both private equity and hedge fund vehicles, focusing on creating long-term value through a research-intensive, analytic process. While not a drug developer itself, Richmond Hill is a significant player in the biotech ecosystem, providing capital and strategic guidance to clinical-stage companies and established healthcare entities. The firm is known for its deep expertise in identifying undervalued assets and navigating complex regulatory and operational landscapes within the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Richmond Hill.